ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $707,000 | -51.2% | 288,763 | -5.9% | 0.05% | -48.9% |
Q4 2019 | $1,448,000 | +24.9% | 306,786 | +13.3% | 0.09% | -10.9% |
Q3 2019 | $1,159,000 | -28.6% | 270,870 | -2.8% | 0.10% | -22.9% |
Q2 2019 | $1,624,000 | -7.8% | 278,609 | -49.4% | 0.13% | +89.9% |
Q3 2018 | $1,762,000 | -0.7% | 550,559 | -6.2% | 0.07% | -1.4% |
Q2 2018 | $1,774,000 | +1.7% | 587,255 | +46.8% | 0.07% | -1.4% |
Q1 2018 | $1,744,000 | +43.8% | 400,060 | +36.5% | 0.07% | +29.1% |
Q4 2017 | $1,213,000 | -6.4% | 293,082 | +38.8% | 0.06% | -21.4% |
Q3 2017 | $1,296,000 | +1.7% | 211,142 | +3.1% | 0.07% | -33.3% |
Q2 2017 | $1,274,000 | +45.6% | 204,744 | +48.4% | 0.10% | +20.7% |
Q1 2017 | $875,000 | +42.3% | 137,976 | +20.0% | 0.09% | +16.0% |
Q4 2016 | $615,000 | +0.5% | 114,980 | +5.8% | 0.08% | -7.4% |
Q3 2016 | $612,000 | -0.6% | 108,720 | -3.1% | 0.08% | -6.9% |
Q2 2016 | $616,000 | -44.2% | 112,156 | -24.6% | 0.09% | +27.9% |
Q1 2016 | $1,104,000 | +71.2% | 148,806 | +91.7% | 0.07% | -17.1% |
Q4 2015 | $645,000 | – | 77,605 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |